Kova Tirzepatide Review: Renewal Prices and Early Cancellation

Kova's tirzepatide offer makes the difference between introductory and continuing cost visible: $299 for the first month, then $399 monthly. Longer plans advertise lower rates, but their payment and early-cancellation terms need as much attention as the discount.¹²

Our verdict: the published price ladder is useful, while the term commitment makes this a decision about flexibility as well as cost. Ask which plan type you are selecting before accepting an offer with monthly installments. A monthly payment does not necessarily make a plan freely cancellable without a financial adjustment.

Compare the first month with the next one

Kova lists compounded tirzepatide at $299 initially and $399 thereafter on the one-month option. Its longer-plan figures are $747 for three months, $1,374 for six months and $2,388 for twelve months, corresponding to displayed monthly rates of $249, $229 and $199. The site describes both upfront and monthly-payment options.¹

The important starting budget is therefore not just $299. Ask which charge applies after the introductory month, whether a discount depends on a fixed term and when the next payment is taken. Someone who expects to reassess after a short trial should compare the flexible option against the cost of ending a discounted term early.

The lower annual equivalent involves a much longer relationship with the service. Before choosing it, consider whether you know the support arrangements, medication tolerance and practical ordering process well enough to commit. A payment schedule should be clear about the total obligation even if payments are spread across months.

The current terms distinguish plan types

Kova's terms separate fixed-term commitment plans from multi-month plans. For a voluntarily ended fixed-term commitment without an applicable permitted cancellation right, completed program months may be repriced at the disclosed standard rate through a Cancellation Rate Adjustment. The formula, limits and selected enrollment disclosure matter.²

This is more specific than simply saying cancel anytime. Ask whether your selected plan uses that provision, what standard rate applies and the maximum adjustment that could result. Turning off automatic renewal is also different from ending the current term early.

For prepaid multi-month arrangements, request the refund calculation and treatment of already dispensed medication. If financing is used, ask how an approved refund reaches the financing provider and affects remaining payments. Ending services does not automatically erase a separate financing agreement.²

A useful comparison is a written example: what would you owe if you stopped after the first completed month? Have the company answer for your exact plan rather than applying an assumed calculation from another offer. Keep that answer with the checkout confirmation.

What Kova says about care and dispensing

The program describes clinician review, prescription eligibility assessment, fulfillment coordination, applicable check-ins and educational resources. It says initial treatment is not charged unless approved. Kova names a pharmacy network including Absolute, Southend, Strive and Pharmacy Boudreaux's, while noting state and clinical limitations.¹

A network list does not identify your individual dispenser. Ask which pharmacy will fill the prescription, whether you will be told of any change and how to reach both the prescriber and pharmacist. Also establish whether follow-ups are live visits, asynchronous reviews or another format available in your state.

Kova's terms separate recurring billing from the timing of later clinical reviews and refill steps. Missing a refill request does not automatically cancel the plan.² Build a reminder around both the clinical requirements and billing date. This avoids assuming that no shipment means no charge.

Compounded medication requires its own questions

The reviewed tirzepatide offer is compounded, not FDA-approved Zepbound. The compounded tirzepatide guide explains why approval, formulation and individual medical need should remain separate from subscription pricing.

Ask the clinician to explain the proposed formula and the pharmacy to provide clear label and concentration instructions. If you are switching from another provider, supply the current prescription rather than carrying forward syringe assumptions. A discount is not a reason to select a higher dose or a different route.

For approved branded pricing, our Zepbound cost guide provides another reference. Add the required care fees and match supply periods when comparing. A large prepaid total and a medication-only monthly quote cannot be fairly compared by their smallest displayed numbers.

Who should compare Kova further?

Kova is relevant when you value a visible introductory/renewal ladder and are comfortable evaluating a term commitment. Its main limitation is that the lower monthly figure may come with cancellation economics that a flexible customer would not expect. Paid periods and dispensed prescriptions also have refund limits.²

Read our Lavender Sky Health review for a different ordering structure. With Kova, the key document is the plan-specific agreement explaining payment, early cancellation, pharmacy assignment and ongoing clinical access. Those terms determine whether the discount is useful for your circumstances.

The Actin review offers a different one-month-versus-term comparison. If you prefer to examine one-time purchasing before choosing recurring payments, compare the structures in the Revive Longevity review.

Compare Enhanced for another compounded-treatment subscription. Review the renewal quote, care arrangements and cancellation terms individually rather than assuming the same advertised starting price buys the same service.